Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Capital Employed (2017 - 2025)

Anaptysbio filings provide 9 years of Return on Capital Employed readings, the most recent being 0.15% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 22.0% year-over-year to 0.15%, compared with a TTM value of 0.15% through Dec 2025, up 22.0%, and an annual FY2025 reading of 0.12%, up 20.0% over the prior year.
  • Return on Capital Employed hit 0.15% in Q4 2025 for Anaptysbio, down from 0.18% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.18% in Q3 2025, with the low at 0.43% in Q2 2024.
  • Median Return on Capital Employed over the past 5 years was 0.14% (2022), compared with a mean of 0.15%.
  • The sharpest move saw Return on Capital Employed dropped -22bps in 2022, then skyrocketed 54bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.11% in 2021, then crashed by -78bps to 0.2% in 2022, then crashed by -94bps to 0.38% in 2023, then surged by 82bps to 0.07% in 2024, then surged by 317bps to 0.15% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.15%, 0.18%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.